How would you like the money? canada med store The latest results included special items of $0.9 billion, primarily related to an increase in the accrual for litigation expenses, in-process research and development expense, and integration and transaction costs related to the acquisition of Synthes, Inc. Last year's net earnings included after-tax special items of about $0.6 billion.